Author

Anna S. Guan

23andMe (United States)ORCID 0000-0003-3802-2849Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aaron Kleinman· 1 shared Adolfo CorreaiD· 1 shared André FrankeiD· 1 shared Andrea SaltzmaniD· 1 shared Anne O’Donnell‐LuriaiD· 1 shared Arcturus Wang· 1 shared Babak AlipanahiiD· 1 shared Ben WeisburdiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron Kleinman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsNature MedicinePeer-reviewedMay 27, 2020

Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease

Nicola Whiffin, Irina M. Armean, Aaron Kleinman…·Matthew B. Harms

The paper analyzes loss-of-function variants in LRRK2 across large genomic datasets to assess the safety of partial LRRK2 inhibition as a Parkinson's disease therapy.

126 citationstop 1%

humanwhole-exome sequencing

𝕏 PostBluesky